Skip To Main Content
de Vlam on Muck Rack

de Vlam

As seen in: Annals of the Rheumatic Diseases, Frontiers, SAGE Publishing, University of Oxford, Arthritis Research & Therapy, The Journal of Rheumatology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to de Vlam’s profile

Articles by de Vlam

GRAPPA 2025 Annual Meeting: advances in psoriatic disease research from pilot grant awardees

|
By Jan Herman, de Vlam
| gla.ac.uk
Spangenberg, A. et al. (2026) GRAPPA 2025 Annual Meeting: advances in psoriatic disease research from pilot grant awardees. Journal of Rheumatology, 53(5), (doi: 10.3899/jrheum.2026-0372) (PMID:42140635) (Early Online Publication) Text 386772.pdf - Published Version 218kB Abstract Key advances from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) pilot research grant program were presented at the GRAPPA 2025 annual meeting.
Open in Who Shared Issue with article?

Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

|
By de Vlam, Osterling Koskinen, Abdel-Kader Martin
| University of Oxford
Publication status: In press Peer review status: Peer reviewed Cite APA Style Taylor, P. C., Mease, P. J., de Vlam, K., Mpofu, S., Wetzel, D., Stevens, A. M., Wiens, B., Osterling Koskinen, L., Ohlman, S., Feldwisch, J., Frejd, F. Y., Brun, N. C., Brandt-Juergens, J., Drescher, E., Dokoupilova, E., Rowińska-Osuch, A., Abdel-Kader Martin, N., & Behrens, F. (2025). Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.
Open in Who Shared Issue with article?

Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study | Arthritis Research & Therapy | Full

|
By de Vlam, Janssen-Cilag BV, hospitals Leuven
| Arthritis Research & Therapy Verified
In the PsABio real-world study, PROs improved from baseline to 3 years in a broadly similar manner for both ustekinumab and TNFi treatment cohorts. Ustekinumab has previously been shown to improve PROs in patients with PsA in a RCT setting.
Open in Who Shared Issue with article?

Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study

|
By de Vlam
| gla.ac.uk
Gossec, L. et al. (2023) Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study. Arthritis Research and Therapy, 25, 109. (doi: 10.1186/s13075-023-03058-y) (PMID:37353788) (PMCID:PMC10288720) Text 301497.pdf - Published Version Available under License Creative Commons Attribution.
Open in Who Shared Issue with article?

Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data

|
By van Kuijk, de Vlam, van der Horst-Bruinsma, Arno W.R
| gla.ac.uk
Van Kuijk, A. W.R. et al. (2023) Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data. Rheumatology, (doi: 10.1093/rheumatology/kead089) (PMID:36810788) (Early Online Publication) Text 293265.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial.
Open in Who Shared Issue with article?

Frontiers | SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: a prospective, real-life Belgian cohort study -the BELCOMID study

|
By hospitals Leuven, KU Leuven, de Vlam, East Flanders
| Frontiers
Jeroen Geldof1, 2*, Marie Truyens1, 2, João Sabino3, 4, 5, Marc Ferrante3, 4, 5, Jo Lambert6, Hilde Lapeere6, Tom Hillary7, An V.
Open in Who Shared Issue with article?

Frankly, We Do Give a Damn: The Relationship Between Profanity and Honesty - Gilad Feldman, Huiwen Lian, Michal Kosinski, David Stillwell, 2017

|
By de Vlam, s’ Note, Gilad Feldman, Huiwen Lian
| SAGE Publishing
Frankly my dear, I don’t give a damn. Gone with the Wind (1939) Profane as it is, this memorable line by the character Rhett Butler in the film Gone with the Wind profoundly conveys Butler’s honest thoughts and feelings. However, it was the use of this profane word that led to a US$5,000 fine against the film’s production for violating the Motion Picture Production Code.
Open in Who Shared Issue with article?
Show More